# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | KX2-361 | KX2-361 | IC50 | = | 60 | nM | ALA4371210 | 7.22 | nM | Mus musculus | ||
2. | Dasatinib | 2, BMS-354825 | Activity | = | 91 | nM | ALA4807717 | nM | Mus musculus | |||
3. | Dasatinib | 2, BMS-354825 | INH | = | 100 | % | ALA4807716 | % | Mus musculus | |||
4. | Dasatinib | 2, BMS-354825 | INH | = | 44 | % | ALA4807715 | % | Mus musculus | |||
5. | AGL 2043 | Tyrphostin AGL-2043 | IC50 | > | 30 | uM | ALA4342555 | nM | Mus musculus | |||
6. | ALA4213787 | Z9j; CU-CPT-Z9j | INH | 0 | ALA4195501 | Dose-dependent effect | % | Mus musculus | ||||
7. | ALA3929003 | 24 | INH | 0 | ALA3861157 | % | Mus musculus | |||||
8. | ALA3958805 | 25 | INH | 0 | ALA3861157 | % | Mus musculus | |||||
9. | ALA3890315 | 17 | INH | < | 50 | % | ALA3861156 | % | Mus musculus | |||
10. | ALA140 | SID17389087 | IC50 | = | 2.2 | uM | ALA3861108 | 5.66 | nM | Mus musculus | ||
11. | ALA3984647 | 44 | IC50 | = | 8.5 | uM | ALA3861108 | 5.07 | nM | Mus musculus | ||
12. | ALA3969544 | 43 | IC50 | = | 37.3 | uM | ALA3861108 | 4.43 | nM | Mus musculus | ||
13. | ALA3939629 | 42 | IC50 | = | 24.1 | uM | ALA3861108 | 4.62 | nM | Mus musculus | ||
14. | ALA3985713 | 39 | IC50 | = | 28.2 | uM | ALA3861108 | 4.55 | nM | Mus musculus | ||
15. | ALA3907638 | 38 | IC50 | = | 53.8 | uM | ALA3861108 | 4.27 | nM | Mus musculus | ||
16. | ALA3924218 | 37 | IC50 | = | 40.9 | uM | ALA3861108 | 4.39 | nM | Mus musculus | ||
17. | ALA3926408 | 36 | IC50 | = | 25.6 | uM | ALA3861108 | 4.59 | nM | Mus musculus | ||
18. | ALA3919374 | 34 | IC50 | = | 11.2 | uM | ALA3861108 | 4.95 | nM | Mus musculus | ||
19. | ALA3953825 | 33 | IC50 | = | 41.3 | uM | ALA3861108 | 4.38 | nM | Mus musculus | ||
20. | ALA3982525 | 32 | IC50 | = | 138.4 | uM | ALA3861108 | nM | Mus musculus |